Vertex Pharmaceuticals (VRTX) Shares Repurchased (2018 - 2025)
Historic Shares Repurchased for Vertex Pharmaceuticals (VRTX) over the last 7 years, with Q3 2025 value amounting to $1.1 billion.
- Vertex Pharmaceuticals' Shares Repurchased rose 24809.88% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 billion, marking a year-over-year increase of 15386.82%. This contributed to the annual value of $1.2 billion for FY2024, which is 17528.06% up from last year.
- Vertex Pharmaceuticals' Shares Repurchased amounted to $1.1 billion in Q3 2025, which was up 24809.88% from $391.8 million recorded in Q2 2025.
- In the past 5 years, Vertex Pharmaceuticals' Shares Repurchased registered a high of $1.1 billion during Q3 2025, and its lowest value of $28.3 million during Q2 2023.
- Moreover, its 4-year median value for Shares Repurchased was $344.2 million (2021), whereas its average is $351.4 million.
- Examining YoY changes over the last 5 years, Vertex Pharmaceuticals' Shares Repurchased showed a top increase of 103180.21% in 2024 and a maximum decrease of 120.48% in 2024.
- Quarter analysis of 4 years shows Vertex Pharmaceuticals' Shares Repurchased stood at $368.2 million in 2021, then tumbled by 59.4% to $149.5 million in 2023, then skyrocketed by 179.53% to $417.9 million in 2024, then soared by 156.31% to $1.1 billion in 2025.
- Its Shares Repurchased stands at $1.1 billion for Q3 2025, versus $391.8 million for Q2 2025 and $426.1 million for Q1 2025.